JP2004505640A5 - - Google Patents

Download PDF

Info

Publication number
JP2004505640A5
JP2004505640A5 JP2002518278A JP2002518278A JP2004505640A5 JP 2004505640 A5 JP2004505640 A5 JP 2004505640A5 JP 2002518278 A JP2002518278 A JP 2002518278A JP 2002518278 A JP2002518278 A JP 2002518278A JP 2004505640 A5 JP2004505640 A5 JP 2004505640A5
Authority
JP
Japan
Prior art keywords
peptide
human urocortin
dna
identification number
isolated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002518278A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004505640A (ja
JP4873825B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/023976 external-priority patent/WO2002012307A1/en
Publication of JP2004505640A publication Critical patent/JP2004505640A/ja
Publication of JP2004505640A5 publication Critical patent/JP2004505640A5/ja
Application granted granted Critical
Publication of JP4873825B2 publication Critical patent/JP4873825B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002518278A 2000-08-04 2001-07-31 ウロコルチン蛋白質及びその利用 Expired - Fee Related JP4873825B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US22325500P 2000-08-04 2000-08-04
US60/223,255 2000-08-04
US27396901P 2001-03-07 2001-03-07
US60/273,969 2001-03-07
PCT/US2001/023976 WO2002012307A1 (en) 2000-08-04 2001-07-31 Urocortin proteins and uses thereof

Publications (3)

Publication Number Publication Date
JP2004505640A JP2004505640A (ja) 2004-02-26
JP2004505640A5 true JP2004505640A5 (https=) 2008-09-25
JP4873825B2 JP4873825B2 (ja) 2012-02-08

Family

ID=26917597

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002518278A Expired - Fee Related JP4873825B2 (ja) 2000-08-04 2001-07-31 ウロコルチン蛋白質及びその利用

Country Status (16)

Country Link
US (4) US6838274B2 (https=)
EP (1) EP1305334B1 (https=)
JP (1) JP4873825B2 (https=)
KR (1) KR100879232B1 (https=)
CN (1) CN1484650B (https=)
AT (1) ATE408622T1 (https=)
AU (2) AU8468301A (https=)
CA (1) CA2418144C (https=)
CY (1) CY1110424T1 (https=)
DE (1) DE60135850D1 (https=)
DK (1) DK1305334T3 (https=)
ES (1) ES2313978T3 (https=)
IL (2) IL154102A0 (https=)
PT (1) PT1305334E (https=)
RU (1) RU2278871C2 (https=)
WO (1) WO2002012307A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002012307A1 (en) * 2000-08-04 2002-02-14 Research Development Foundation Urocortin proteins and uses thereof
US20020082409A1 (en) 2000-10-26 2002-06-27 Hsu Sheau Yu Stresscopins and their uses
US6670140B2 (en) * 2001-03-06 2003-12-30 The Procter & Gamble Company Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
IL154553A0 (en) * 2001-03-15 2003-09-17 Res Dev Foundation Urocortin-iii and uses thereof
US6936585B2 (en) 2002-01-16 2005-08-30 The Procter & Gamble Company Corticotropin releasing factor 2 receptor agonists
WO2008047241A2 (en) * 2006-10-16 2008-04-24 Conjuchem Biotechnologies Inc. Modified corticotropin releasing factor peptides and uses thereof
EP2167094A2 (en) 2007-06-13 2010-03-31 Research Development Foundation Methods for treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating crf receptor signaling
US20100204145A1 (en) * 2007-09-11 2010-08-12 Dorian Bevec Use of a peptide as a therapeutic agent
AU2008303922A1 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Use of the peptide His-Ser-Leu-Gly-Lys-Trp-Leu-Gly-His-Pro-Asp-Lys-Phe alone or in combination with the peptide Gly-Ard-Gly-Asp-Asn-Pro-OH as a therapeutic agent
US20120238509A1 (en) * 2009-08-28 2012-09-20 Research Development Foundation Urocortin 2 analogs and uses thereof
US9314506B2 (en) 2011-10-24 2016-04-19 Research Development Foundation Methods for increasing insulin secretion by co-stimulation of corticotropin-releasing factor receptors
CA2864100A1 (en) 2012-02-14 2013-08-22 The Regents Of The University Of California Systemic delivery and regulated expression of paracrine genes for cardiovascular diseases and other conditions
JOP20170153A1 (ar) * 2016-07-15 2019-01-30 Lilly Co Eli نظائر urocortin-2 جديدة معدلة بحمض دهني لعلاج داء السكري وأمراض الكلى المزمنة
US12472158B2 (en) 2019-02-27 2025-11-18 Vanderbilt University Methods of treating trigeminal nerve pain
CN110826145B (zh) * 2019-09-09 2020-08-28 西安工业大学 基于超启发式马氏链进化的汽车多参数运行工况设计方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2223792A1 (en) 1995-06-13 1997-01-03 The Salk Institute For Biological Studies Urocortin peptides
WO2002012307A1 (en) 2000-08-04 2002-02-14 Research Development Foundation Urocortin proteins and uses thereof
US20020082409A1 (en) 2000-10-26 2002-06-27 Hsu Sheau Yu Stresscopins and their uses
US6670140B2 (en) * 2001-03-06 2003-12-30 The Procter & Gamble Company Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors

Similar Documents

Publication Publication Date Title
Odell et al. Antibacterial activity of peptides homologous to a loop region in human lactoferrin
JP2004505640A5 (https=)
Andreu et al. Solid-phase synthesis of cecropin A and related peptides.
JP2002500043A5 (https=)
HUT70459A (en) Analogs of pth
NZ505880A (en) IL-18 receptor polypeptides
Callaway et al. Modification of the C terminus of cecropin is essential for broad-spectrum antimicrobial activity
HU202921B (en) Process for producing coding dns for human tumor necrosis factor the corresponding polypeptide with utilizing them and pharmaceutical compositions containing this polypeptide as active component
JP2002514418A5 (https=)
RU2003105897A (ru) Белки урокортина и их применения
PT1931705E (pt) Processo para a amidação de polipéptidos com aminoácidos básicos na extremidade c-terminal recorrendo a endoproteases específicas
CA2328140A1 (en) Method of inhibiting osteoclast activity
JP2003530124A5 (https=)
CA2461443A1 (en) Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
Ma et al. The complete amino acid sequence for brain β spectrin (β fodrin): relationship to globin sequences
JP2002517193A5 (https=)
WO1994010199A1 (en) Expression and purification of cloned human alpha-fetoprotein
AU5776799A (en) Modified hcv peptide vaccines
DE60336353D1 (de) Rekombinantes protein mit krebsunterdrückender wirkung, sein codierendes gen und seine verwendung
US6255067B1 (en) cDNA encoding peptidyl-glycine alpha-amidating monooxygenase (PAM)
JP2003334088A5 (https=)
AU9391598A (en) Beta-defensins
CN101848723B (zh) 细菌素诱导者肽
CA2301902A1 (en) Novel extracellular serine protease
US6077827A (en) Family of peptides known as xenoxins